Bharat Biotech’s Intranasal Vaccine Gets Nod For Phase 2/3 Trials ...Middle East

Ommcom News - News
Bharat Biotech’s Intranasal Vaccine Gets Nod For Phase 2/3 Trials
New Delhi: India’s first intranasal vaccine, being developed by Bharat Biotech in collaboration with the Department of Biotechnology and its PSU, the Biotechnology Industry Research Assistance Council (BIRAC), on Friday got regulatory approval for Phase 2/3 trials. “Bharat Biotech’s intranasal vaccine is the first nasal vaccine that has received the regulatory approval for Phase 2/3 […] The post Bharat Biotech’s Intranasal Vaccine Gets Nod For Phase 2/3 Trials appeared first on Ommcom News.

Hence then, the article about bharat biotech s intranasal vaccine gets nod for phase 2 3 trials was published today ( ) and is available on Ommcom News ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Bharat Biotech’s Intranasal Vaccine Gets Nod For Phase 2/3 Trials )

Apple Storegoogle play

Last updated :

Also on site :